Guangzhou, China

Jian Lin

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Bio-Thera Solutions, Ltd.. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jian Lin. Retrieved from https://idiyas.com/inventor/jian-lin-z1b3pol3

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jian Lin - Innovator in Antibody Research

Introduction

Jian Lin is a prominent inventor based in Guangzhou, China. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. His work is instrumental in advancing medical treatments and improving patient outcomes.

Latest Patents

Jian Lin holds a patent for an innovative invention titled "Antibody Binding to PD-1." This patent represents a crucial step in the fight against various diseases, including cancer, by targeting the PD-1 protein, which plays a significant role in immune response regulation.

Career Highlights

Currently, Jian Lin is associated with Bio-Thera Solutions, Ltd., a company dedicated to developing innovative biopharmaceuticals. His expertise and dedication have positioned him as a key player in the company's research and development efforts.

Collaborations

Throughout his career, Jian Lin has collaborated with notable colleagues, including Haitao Yue and Shujun Pei. These partnerships have fostered a collaborative environment that enhances innovation and accelerates the development of new therapies.

Conclusion

Jian Lin's contributions to antibody research and his innovative spirit continue to impact the biotechnology field positively. His work exemplifies the importance of innovation in advancing healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…